Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China flag China · Delayed Price · Currency is CNY
18.49
+0.05 (0.27%)
Sep 4, 2026, 3:04 PM CST

SHE:000623 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,3231,1631,1071,7201,4381,743
Short-Term Investments
----788704
Trading Asset Securities
1,5921,8001,5681,6581,6402,189
Cash & Short-Term Investments
2,9162,9632,6753,3783,8664,635
Cash Growth
-8.96%10.76%-20.81%-12.62%-16.59%2.71%
Accounts Receivable
843.271,0011,1571,4071,056964.31
Other Receivables
823.6725.2523.1829.9860.3168.53
Receivables
1,6671,0271,1811,4371,1161,033
Inventory
823.92802.1936.9872.35874.57591.88
Prepaid Expenses
-----0.16
Other Current Assets
54.8231.3840.4157.55124.6965.59
Total Current Assets
5,4614,8234,8335,7455,9826,326
Property, Plant & Equipment
2,2972,3562,5582,5342,3392,296
Long-Term Investments
27,48226,47324,64723,00321,89119,637
Other Intangible Assets
397.38404.52437.32435.35365.08359.61
Long-Term Deferred Tax Assets
317.38269.99326.23309.84303.12164.27
Long-Term Deferred Charges
26.5337.63111.57163.96212.25188.02
Other Long-Term Assets
6754.0488.3375.7789.8396.53
Total Assets
36,04934,41833,00232,26631,18229,067

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
310.67310.42425.71418.59450.97238.22
Accrued Expenses
90.1113.71106.87148.94183.15111.71
Short-Term Debt
925.62903.021,255678.31651.27355.52
Current Portion of Long-Term Debt
1,00524.07-2,315--
Current Portion of Leases
4.779.2922.4817.8818.2325.41
Current Income Taxes Payable
2.523.595.928.2811.5219.31
Current Unearned Revenue
39.7531.6836.2526.2682.2518.36
Other Current Liabilities
939.34618.28611.75834.8817.97687.19
Total Current Liabilities
3,3172,0142,4644,4682,2151,456
Long-Term Debt
302.11,299995.22-2,3032,211
Long-Term Leases
3.673.1816.5121.4917.5523.38
Long-Term Unearned Revenue
204.5212.98223.87247.38281.6313.86
Long-Term Deferred Tax Liabilities
0.581.3620.1730.0326.0624.21
Other Long-Term Liabilities
13.12-----
Total Liabilities
3,8413,5313,7204,7674,8444,029

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
1,1961,1961,1961,1681,1631,163
Additional Paid-In Capital
4,8514,8984,8524,0353,9473,980
Retained Earnings
25,97324,27522,46621,87120,74119,243
Treasury Stock
-420.01-420.01-300-720.07-570.07-400.03
Comprehensive Income & Other
388.54717.38814.1856.99753.71873.11
Total Common Equity
31,98930,66729,02827,21226,03424,859
Minority Interest
218.47220.23254.65288.01303.54179.26
Shareholders' Equity
32,20730,88729,28227,50026,33825,039
Total Liabilities & Equity
36,04934,41833,00232,26631,18229,067

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
2,2412,2392,2893,0322,9902,616
Net Cash (Debt)
674.79724385.96346.02875.842,020
Net Cash Growth
-28.23%87.58%11.54%-60.49%-56.63%-0.57%
Net Cash Per Share
0.580.620.330.270.671.60
Filing Date Shares Outstanding
1,1721,1721,1721,1231,1271,139
Total Common Shares Outstanding
1,1721,1721,1801,1231,1271,139
Working Capital
2,1442,8092,3691,2773,7674,870
Book Value Per Share
27.2926.1624.6124.2323.1021.83
Tangible Book Value
31,59130,26228,59026,77625,66924,500
Tangible Book Value Per Share
26.9525.8124.2423.8422.7821.51
Buildings
2,2962,2902,2872,2022,1382,039
Machinery
1,5381,5341,5121,4911,4131,321
Construction In Progress
330.05324.63424.87349.54177.36179.32